MicroTransponder
Dallas
About MicroTransponder
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases with a focus on vagus nerve stimulation (VNS). Its first commercial product, Vivistim, is FDA approved for ischemic stroke survivors with moderate to severe upper limb impairment six months or more after their stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $180.1M
- Funding stage: Late Stage Venture
- Last round: Series F (Mar 2025)
- Website: microtransponder.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/microtransponder-56496 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.